社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
HUAT8
IP属地：未知
+关注
帖子 · 63
帖子 · 63
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
HUAT8
HUAT8
·
2021-11-15
Hope the bullish sentiment continues!
非常抱歉，此主贴已删除
看
1,527
回复
2
点赞
7
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-14
Yesss
Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?
Meta Platforms Inc is having a strong close thus far to end the week, up almost 3.5% and only $7 off
Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?
看
1,463
回复
评论
点赞
4
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-12
👍
非常抱歉，此主贴已删除
看
1,677
回复
评论
点赞
3
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-09
[开心]
非常抱歉，此主贴已删除
看
1,777
回复
评论
点赞
4
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-05
Hmm I thought the only unsatisfactory result is the fall in gross margin, which is a result of some non-recurring expenses[思考]
Bionano Genomics stock tanked more than 8% in premarket trading
Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $
Bionano Genomics stock tanked more than 8% in premarket trading
看
1,715
回复
1
点赞
3
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-04
To the 🌒
Fastly stock rallied 10% in premarket trading
Fastly stock is headed higher in premarket trading Thursday after the content delivery network and s
Fastly stock rallied 10% in premarket trading
看
1,810
回复
评论
点赞
1
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-04
👍
Tesla shares surged more than 2% to a new high in premarket trading
Tesla shares surged more than 2% to a new high in premarket trading.
Tesla shares surged more than 2% to a new high in premarket trading
看
2,403
回复
评论
点赞
3
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-11-03
Tonight is crucial
非常抱歉，此主贴已删除
看
1,813
回复
1
点赞
3
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-10-29
$ASML Holding NV(ASML)$
Rise rise
看
1,582
回复
评论
点赞
1
编组 21备份 2
分享
举报
HUAT8
HUAT8
·
2021-06-20
Next week let's see
非常抱歉，此主贴已删除
看
1,269
回复
评论
点赞
5
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3554811401768317","uuid":"3554811401768317","gmtCreate":1591858642071,"gmtModify":1615600810159,"name":"HUAT8","pinyin":"huat8","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":27,"headSize":136,"tweetSize":63,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.08","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.74%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.13%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":873626047,"gmtCreate":1636939567395,"gmtModify":1636939567549,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"Hope the bullish sentiment continues!","listText":"Hope the bullish sentiment continues!","text":"Hope the bullish sentiment continues!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/873626047","repostId":"2183536049","repostType":4,"isVote":1,"tweetType":1,"viewCount":1527,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873968058,"gmtCreate":1636845827862,"gmtModify":1636845832465,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"Yesss","listText":"Yesss","text":"Yesss","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873968058","repostId":"1116750872","repostType":4,"repost":{"id":"1116750872","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1636761765,"share":"https://www.laohu8.com/m/news/1116750872?lang=&edition=full","pubTime":"2021-11-13 08:02","market":"us","language":"en","title":"Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?","url":"https://stock-news.laohu8.com/highlight/detail?id=1116750872","media":"Benzinga","summary":"Meta Platforms Inc is having a strong close thus far to end the week, up almost 3.5% and only $7 off","content":"<p><b>Meta Platforms Inc</b> is having a strong close thus far to end the week, up almost 3.5% and only $7 off the weekly highs.</p>\n<p><b>What Happened:</b> While the volume of shares traded is solid at 17 million vs. the 10 day average of 21 million, options traders are quite active on the day, trading more than 672,970 options with 476,002 being calls and 196,968 being puts. This comes out to about 7 out of every 10 options being calls (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/c08237f8d7c163047e56072f027073d5\" tg-width=\"1001\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p>\n<p><b>What It Matters:</b>Prior to this Friday, there were 1,519,000 calls and 1,207,750 puts for a total of 2,726,000 options. Hence this Friday's options activity and flows of 672,970 comprise 25% of the total option flows out there.</p>\n<p>Any time a stock trades 25% of its total options in one day, it means options traders are particularly active in the stock.</p>\n<p>Of note, only 11% of the options were set to expire this Friday (~300,000 options) so today's 672,970 options suggest a lot more forward-looking flows.</p>\n<p><b>What's Next:</b>Looking at the option flows expiring next week on Nov. 19, you can see on the call side the majority of volume and open interest is between the $330 and $360 strikes. And on the put side, there is a consistent but small volume between the $340 and $300 strikes (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/e74f74fdf39ce74de7e0d6a88eb349c8\" tg-width=\"1743\" tg-height=\"650\" width=\"100%\" height=\"auto\"></p>\n<p>This suggests bullish traders are targeting between $330 and $360, but don't have much appetite above that. Meanwhile, bearish options traders don't see much downside below $300.</p>\n<p>It should be noted the steady volume of puts from $340 to $300 appears to be a mix of bullish traders selling cash-secured puts down to the $322.5 strike, but likely long stock traders seeking protection below that as the premium is very low.</p>\n<p>Hence bullish traders will want to see the $360 strike cleared by next week to lift their expectations higher while bears will want to see a weekly close below $300 to open up the downside.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Meta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMeta Platforms Closes The Week Strong: Are Option Traders Targeting All-Time Highs?\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-13 08:02</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Meta Platforms Inc</b> is having a strong close thus far to end the week, up almost 3.5% and only $7 off the weekly highs.</p>\n<p><b>What Happened:</b> While the volume of shares traded is solid at 17 million vs. the 10 day average of 21 million, options traders are quite active on the day, trading more than 672,970 options with 476,002 being calls and 196,968 being puts. This comes out to about 7 out of every 10 options being calls (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/c08237f8d7c163047e56072f027073d5\" tg-width=\"1001\" tg-height=\"277\" width=\"100%\" height=\"auto\"></p>\n<p><b>What It Matters:</b>Prior to this Friday, there were 1,519,000 calls and 1,207,750 puts for a total of 2,726,000 options. Hence this Friday's options activity and flows of 672,970 comprise 25% of the total option flows out there.</p>\n<p>Any time a stock trades 25% of its total options in one day, it means options traders are particularly active in the stock.</p>\n<p>Of note, only 11% of the options were set to expire this Friday (~300,000 options) so today's 672,970 options suggest a lot more forward-looking flows.</p>\n<p><b>What's Next:</b>Looking at the option flows expiring next week on Nov. 19, you can see on the call side the majority of volume and open interest is between the $330 and $360 strikes. And on the put side, there is a consistent but small volume between the $340 and $300 strikes (image below).</p>\n<p><img src=\"https://static.tigerbbs.com/e74f74fdf39ce74de7e0d6a88eb349c8\" tg-width=\"1743\" tg-height=\"650\" width=\"100%\" height=\"auto\"></p>\n<p>This suggests bullish traders are targeting between $330 and $360, but don't have much appetite above that. Meanwhile, bearish options traders don't see much downside below $300.</p>\n<p>It should be noted the steady volume of puts from $340 to $300 appears to be a mix of bullish traders selling cash-secured puts down to the $322.5 strike, but likely long stock traders seeking protection below that as the premium is very low.</p>\n<p>Hence bullish traders will want to see the $360 strike cleared by next week to lift their expectations higher while bears will want to see a weekly close below $300 to open up the downside.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FB":"ProShares S&P 500 Dynamic Buffer ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116750872","content_text":"Meta Platforms Inc is having a strong close thus far to end the week, up almost 3.5% and only $7 off the weekly highs.\nWhat Happened: While the volume of shares traded is solid at 17 million vs. the 10 day average of 21 million, options traders are quite active on the day, trading more than 672,970 options with 476,002 being calls and 196,968 being puts. This comes out to about 7 out of every 10 options being calls (image below).\n\nWhat It Matters:Prior to this Friday, there were 1,519,000 calls and 1,207,750 puts for a total of 2,726,000 options. Hence this Friday's options activity and flows of 672,970 comprise 25% of the total option flows out there.\nAny time a stock trades 25% of its total options in one day, it means options traders are particularly active in the stock.\nOf note, only 11% of the options were set to expire this Friday (~300,000 options) so today's 672,970 options suggest a lot more forward-looking flows.\nWhat's Next:Looking at the option flows expiring next week on Nov. 19, you can see on the call side the majority of volume and open interest is between the $330 and $360 strikes. And on the put side, there is a consistent but small volume between the $340 and $300 strikes (image below).\n\nThis suggests bullish traders are targeting between $330 and $360, but don't have much appetite above that. Meanwhile, bearish options traders don't see much downside below $300.\nIt should be noted the steady volume of puts from $340 to $300 appears to be a mix of bullish traders selling cash-secured puts down to the $322.5 strike, but likely long stock traders seeking protection below that as the premium is very low.\nHence bullish traders will want to see the $360 strike cleared by next week to lift their expectations higher while bears will want to see a weekly close below $300 to open up the downside.","news_type":1,"symbols_score_info":{"FB":0.9}},"isVote":1,"tweetType":1,"viewCount":1463,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":879659570,"gmtCreate":1636720902837,"gmtModify":1636720906103,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/879659570","repostId":"1138291710","repostType":4,"isVote":1,"tweetType":1,"viewCount":1677,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844679791,"gmtCreate":1636425761800,"gmtModify":1636425762185,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"[开心] ","listText":"[开心] ","text":"[开心]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844679791","repostId":"1197954926","repostType":4,"isVote":1,"tweetType":1,"viewCount":1777,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846490504,"gmtCreate":1636102064007,"gmtModify":1636102064122,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"Hmm I thought the only unsatisfactory result is the fall in gross margin, which is a result of some non-recurring expenses[思考] ","listText":"Hmm I thought the only unsatisfactory result is the fall in gross margin, which is a result of some non-recurring expenses[思考] ","text":"Hmm I thought the only unsatisfactory result is the fall in gross margin, which is a result of some non-recurring expenses[思考]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/846490504","repostId":"1194946622","repostType":2,"repost":{"id":"1194946622","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636101187,"share":"https://www.laohu8.com/m/news/1194946622?lang=&edition=full","pubTime":"2021-11-05 16:33","market":"us","language":"en","title":"Bionano Genomics stock tanked more than 8% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1194946622","media":"Tiger Newspress","summary":"Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $","content":"<p>Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.</p>\n<p><img src=\"https://static.tigerbbs.com/459633281a2e1ef6cef18931e8ba2b92\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p><b>Bionano Genomics, Inc.</b> reported financial results and business achievements for the quarter ended September 30, 2021 and highlighted recent corporate updates.</p>\n<p><i>– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics</i></p>\n<p><i>– Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base</i></p>\n<p><i>– Record number of Saphyr shipments and installations for any quarter to date</i></p>\n<p><i>– Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications</i></p>\n<p><i>– Remaining 2021 milestones on track</i></p>\n<p><i>– Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember 30, 2021</i></p>\n<p>“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.</p>\n<p>Chris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”</p>\n<p><b>Key Business Highlights in Q3</b></p>\n<p>The Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:</p>\n<p>–<b> Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3</b>. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.</p>\n<p>–<b> Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,</b>which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.</p>\n<p>–<b> Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applications</b>supporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.</p>\n<p>– <b>OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centers</b>inthe United States, including Brigham & Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.</p>\n<p>–<b> The largest clinical research study to date evaluating OGM was published in</b><b><i>The Journal of Molecular Diagnostics</i></b>for a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.</p>\n<p>–<b> NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,</b>Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.</p>\n<p>–<b> Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,</b>highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.</p>\n<p>– <b>Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021</b>, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.</p>\n<p>– <b>Added exceptional talent across commercial leadership functions,</b>includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.</p>\n<p><b>Financial Highlights</b></p>\n<p>–<b> Total revenue for the third quarter of 2021 was$4.7 million,</b>up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.</p>\n<p>–<b> Gross margin for the third quarter of 2021 was 24.8%,</b>compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.</p>\n<p>–<b> Third quarter operating expense was$21.8 million,</b>compared to$17.9 million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.</p>\n<p>– <b>AtSeptember 30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 million</b>compared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.</p>\n<p><b>Remaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr</b></p>\n<p>– 4Q21: Interim publication of results from pediatric clinical study</p>\n<p>– 4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study</p>\n<p>– 4Q21: Initial prototype of next gen high throughput Saphyr</p>\n<p>– 4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bionano Genomics stock tanked more than 8% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBionano Genomics stock tanked more than 8% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-05 16:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.</p>\n<p><img src=\"https://static.tigerbbs.com/459633281a2e1ef6cef18931e8ba2b92\" tg-width=\"848\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p>\n<p><b>Bionano Genomics, Inc.</b> reported financial results and business achievements for the quarter ended September 30, 2021 and highlighted recent corporate updates.</p>\n<p><i>– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics</i></p>\n<p><i>– Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base</i></p>\n<p><i>– Record number of Saphyr shipments and installations for any quarter to date</i></p>\n<p><i>– Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications</i></p>\n<p><i>– Remaining 2021 milestones on track</i></p>\n<p><i>– Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember 30, 2021</i></p>\n<p>“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.</p>\n<p>Chris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”</p>\n<p><b>Key Business Highlights in Q3</b></p>\n<p>The Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:</p>\n<p>–<b> Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3</b>. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.</p>\n<p>–<b> Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,</b>which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.</p>\n<p>–<b> Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applications</b>supporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.</p>\n<p>– <b>OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centers</b>inthe United States, including Brigham & Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.</p>\n<p>–<b> The largest clinical research study to date evaluating OGM was published in</b><b><i>The Journal of Molecular Diagnostics</i></b>for a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.</p>\n<p>–<b> NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,</b>Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.</p>\n<p>–<b> Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,</b>highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.</p>\n<p>– <b>Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021</b>, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.</p>\n<p>– <b>Added exceptional talent across commercial leadership functions,</b>includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.</p>\n<p><b>Financial Highlights</b></p>\n<p>–<b> Total revenue for the third quarter of 2021 was$4.7 million,</b>up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.</p>\n<p>–<b> Gross margin for the third quarter of 2021 was 24.8%,</b>compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.</p>\n<p>–<b> Third quarter operating expense was$21.8 million,</b>compared to$17.9 million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.</p>\n<p>– <b>AtSeptember 30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 million</b>compared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.</p>\n<p><b>Remaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr</b></p>\n<p>– 4Q21: Interim publication of results from pediatric clinical study</p>\n<p>– 4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study</p>\n<p>– 4Q21: Initial prototype of next gen high throughput Saphyr</p>\n<p>– 4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BNGO":"Bionano Genomics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194946622","content_text":"Bionano Genomics stock tanked more than 8% in premarket trading after Bionano Genomics Q3 net loss $20.753M, sales $4.66M beat $4.23M estimate.\n\nBionano Genomics, Inc. reported financial results and business achievements for the quarter ended September 30, 2021 and highlighted recent corporate updates.\n– Acquisition of BioDiscovery transforms Bionano from the structural variation company into a data solutions provider with the potential to offer the most comprehensive variant analysis platform in genomics\n– Total revenue of$4.7 million, a 112% year-over-year total revenue increase, driven by growth in the Saphyr® installed base\n– Record number of Saphyr shipments and installations for any quarter to date\n– Launched protocols for ultra-high molecular weight DNA isolation from amniocentesis and chorionic villus sampling (CVS) for prenatal applications\n– Remaining 2021 milestones on track\n– Strong balance sheet with$326.1 millionin cash and short term investments as ofSeptember 30, 2021\n“We had the strongest quarter in Bionano’s history with a record number of Saphyr shipments and installations, including adoptions at several notable sites, including leading hospitals, cytogenetics labs and academic medical centers around the world. With the acquisition of BioDiscovery, a leading software company with best-in-class solutions for analysis, visualization, interpretation and reporting of genomics data. for microarray and next-generation sequencing (NGS), we are transitioningBionano Genomicsfrom being the structural variation company into a data solutions provider. We believe this will enable access to an expanded market opportunity by leveraging the NGS market through software. We are extremely pleased with the progress we are making and the fact that outstanding leaders are joining Bionano to join us in transforming the way the world sees the genome,” commentedErik Holmlin, PhD, Chief Executive Officer ofBionano Genomics.\nChris Stewart, Chief Financial Officer of Bionano added: “Q3 was another excellent quarter. We continued to achieve meaningful year-over-year revenue growth and maintained a strong balance sheet with$326 millionof cash and marketable securities as of the quarter-end. We also remain on track to achieve the milestones we laid out in the first quarter of 2021.”\nKey Business Highlights in Q3\nThe Company executed on its commercialization strategy, built scientific momentum by presenting data at key scientific meetings and drove utilization of Saphyr at key institutions across the globe, with the following highlights:\n– Expanded the installed base of Saphyr systems from 121 at the end of Q2 to 141 at the end of Q3. During the quarter endedSeptember 30,2021, we shipped a total of 24 Saphyr systems to the field, compared to 11 systems shipped in the same quarter in 2020.\n– Sold 3,969 nanochannel array flow cells during the quarter endedSeptember 30, 2021,which is the most flow cells sold in any quarter ever and represents 122% growth over the same quarter in 2020.\n– Commercial release of solutions for isolation of ultra-high molecular weight DNA for prenatal applicationssupporting the use of samples derived from amniocentesis and CVS. Bionano Prep SP Amnio and CVS Culture DNA Isolation Protocol supports both fresh cultures and cryopreserved cells, which expands the markets served for OGM.\n– OGM with Saphyr was adopted at several notable cytogenetics laboratories and academic medical centersinthe United States, including Brigham & Woman’s Hospital, which is using OGM to identify structural variations in constitutional and cancer applications. Outside the US, Saphyr was adopted inAustralia,EuropeandChina.\n– The largest clinical research study to date evaluating OGM was published inThe Journal of Molecular Diagnosticsfor a rare muscle disease, facioscapulohumeral muscular dystrophy, or FSHD, in about 351 patients. The results demonstrated that OGM provided data more quickly, accurately, and reproducibly than the current gold standard method of Southern blot analysis. The findings support the rationale for adopting OGM as an alternative to Southern blot analysis as OGM had a greater sizing accuracy as well as a greater than 99% concordance with Southern blot analysis.\n– NuProbe Global, a global molecular diagnostics leader, adopted Saphyr to be integrated their proprietary tools,Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA), for research and development efforts in reproductive health and oncology liquid biopsies.\n– Saphyr customers and Bionano conducted 10 presentations at the Annual Cancer Genomics Consortium Meeting inmid-August 2021,highlighting the benefits of OGM for clinical research applications in solid tumor analysis, hematological malignancies, products of conception, prenatal and postnatal constitutional genetics. More than 500 participants from around the globe attended virtually, highlighting the strong interest in OGM for cancer genomics.\n– Bionano customers presented 11 presentations on OGM at theEuropean Society of Human Genetics(ESHG) meeting in lateAugust 2021, demonstrating the clinical utility of OGM across many therapeutic application areas, along with the unique capabilities of Bionano’s Saphyr®system to detect all classes of structural variants, across the genome, at a superior resolution relative to traditional techniques.\n– Added exceptional talent across commercial leadership functions,includingAmanda Lettmannas Vice President of Global Customer Experience,Alex Helmas Vice President Strategic Product Marketing,Stephanie Hoyleas Vice President Corporate Marketing,Amanda Hernandezas Vice President of Global Sales Training and Development,Justin Leightonas Vice President and General Manager,Lineagen, andBob Hertsenbergas North America Sales Director.\nFinancial Highlights\n– Total revenue for the third quarter of 2021 was$4.7 million,up 21% from$3.9 millionin the second quarter and up 112% from$2.2 millionin the same period of 2020. The sequential increase was driven by increased demand for our Saphyr optical genome mapping solutions, including increased instrument sales and greater demand for our reagent rental program and consumables. The year-over-year increase was driven by both higher product sales and by the addition of revenue fromLineagen.\n– Gross margin for the third quarter of 2021 was 24.8%,compared to 37.3% in the prior quarter and 33.4% from the third quarter of 2020. The decrease was primarily due to an increase in laboratory and warranty related expense that are expected to be non-recurring.\n– Third quarter operating expense was$21.8 million,compared to$17.9 million in the prior quarter and$11.0 millionin the third quarter of 2020. The sequential increase was mainly due to a$1.8 millionincrease in headcount and related expenses and a$1.5 millionincrease in Research and Development expenses related to expanding our supply chain to produce higher volumes. Third quarter operating expense included$2.8 millionof non-cash stock-based compensation. The year-over-year increase was primarily due to increased headcount-related spending as we build out all facets of our organization to support our expected commercial progress and increased research and development costs.\n– AtSeptember 30, 2021, the Company had cash, cash equivalents, and short-term investments of$326.1 millioncompared to cash and cash equivalents of$38.4 millionatDecember 31, 2020. The increase in cash is primarily due to the equity raises that were completed in the first quarter of 2021.\nRemaining Anticipated Milestones for 2021 – Initiatives to Drive Global Adoption of Saphyr\n– 4Q21: Interim publication of results from pediatric clinical study\n– 4Q21: Validation of LDTs by 3 sites in both our prenatal clinical study and our pediatric clinical study\n– 4Q21: Initial prototype of next gen high throughput Saphyr\n– 4Q21: Reach installed base of 150 systems to achieve a 50% increase over year end 2020","news_type":1,"symbols_score_info":{"BNGO":0.9}},"isVote":1,"tweetType":1,"viewCount":1715,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848402569,"gmtCreate":1636016563543,"gmtModify":1636016564678,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"To the 🌒","listText":"To the 🌒","text":"To the 🌒","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848402569","repostId":"1144080729","repostType":4,"repost":{"id":"1144080729","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636013373,"share":"https://www.laohu8.com/m/news/1144080729?lang=&edition=full","pubTime":"2021-11-04 16:09","market":"us","language":"en","title":"Fastly stock rallied 10% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1144080729","media":"Tiger Newspress","summary":"Fastly stock is headed higher in premarket trading Thursday after the content delivery network and s","content":"<p>Fastly stock is headed higher in premarket trading Thursday after the content delivery network and security software company posted better-than-expected third-quarter results.</p>\n<p><img src=\"https://static.tigerbbs.com/ac59473a8ca3be4035f97c817c4808c2\" tg-width=\"850\" tg-height=\"621\" width=\"100%\" height=\"auto\"></p>\n<p>For the quarter, Fastly posted revenue of $87 million, up 23% from a year earlier, and ahead of the Street consensus forecast of $83.7 million. On a non-GAAP basis, the company lost 11 cents a share, narrower than the Street consensus forecast for a loss of 19 cents a share.</p>\n<p>Fastly said its enterprise customer count grew to 430 from 408 one quarter earlier, while the total customer count increased to 2,748 from 2,581.</p>\n<p>The company noted that after a widely publicized network outage in the second quarter, some customers paused on using the platform. But CEO Joshua Bixby said in a letter to shareholders that the issue has been resolved and the customers are back. “I am pleased to report that our top customers have returned traffic and continue to ramp following significant stability and resilience work by our infrastructure and engineering teams,” he wrote.</p>\n<p>For the December quarter, Fastly is projecting revenue of $90 million to $93 million, with a non-GAAP loss of 16 to 19 cents a share. Street consensus previously had called for revenue of $91.9 million and a loss of 15 cents a share.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Fastly stock rallied 10% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFastly stock rallied 10% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-04 16:09</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Fastly stock is headed higher in premarket trading Thursday after the content delivery network and security software company posted better-than-expected third-quarter results.</p>\n<p><img src=\"https://static.tigerbbs.com/ac59473a8ca3be4035f97c817c4808c2\" tg-width=\"850\" tg-height=\"621\" width=\"100%\" height=\"auto\"></p>\n<p>For the quarter, Fastly posted revenue of $87 million, up 23% from a year earlier, and ahead of the Street consensus forecast of $83.7 million. On a non-GAAP basis, the company lost 11 cents a share, narrower than the Street consensus forecast for a loss of 19 cents a share.</p>\n<p>Fastly said its enterprise customer count grew to 430 from 408 one quarter earlier, while the total customer count increased to 2,748 from 2,581.</p>\n<p>The company noted that after a widely publicized network outage in the second quarter, some customers paused on using the platform. But CEO Joshua Bixby said in a letter to shareholders that the issue has been resolved and the customers are back. “I am pleased to report that our top customers have returned traffic and continue to ramp following significant stability and resilience work by our infrastructure and engineering teams,” he wrote.</p>\n<p>For the December quarter, Fastly is projecting revenue of $90 million to $93 million, with a non-GAAP loss of 16 to 19 cents a share. Street consensus previously had called for revenue of $91.9 million and a loss of 15 cents a share.</p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"FSLY":"Fastly, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144080729","content_text":"Fastly stock is headed higher in premarket trading Thursday after the content delivery network and security software company posted better-than-expected third-quarter results.\n\nFor the quarter, Fastly posted revenue of $87 million, up 23% from a year earlier, and ahead of the Street consensus forecast of $83.7 million. On a non-GAAP basis, the company lost 11 cents a share, narrower than the Street consensus forecast for a loss of 19 cents a share.\nFastly said its enterprise customer count grew to 430 from 408 one quarter earlier, while the total customer count increased to 2,748 from 2,581.\nThe company noted that after a widely publicized network outage in the second quarter, some customers paused on using the platform. But CEO Joshua Bixby said in a letter to shareholders that the issue has been resolved and the customers are back. “I am pleased to report that our top customers have returned traffic and continue to ramp following significant stability and resilience work by our infrastructure and engineering teams,” he wrote.\nFor the December quarter, Fastly is projecting revenue of $90 million to $93 million, with a non-GAAP loss of 16 to 19 cents a share. Street consensus previously had called for revenue of $91.9 million and a loss of 15 cents a share.","news_type":1,"symbols_score_info":{"FSLY":0.9}},"isVote":1,"tweetType":1,"viewCount":1810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":848402147,"gmtCreate":1636016534044,"gmtModify":1636016556323,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"👍","listText":"👍","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/848402147","repostId":"1184547180","repostType":4,"repost":{"id":"1184547180","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636013921,"share":"https://www.laohu8.com/m/news/1184547180?lang=&edition=full","pubTime":"2021-11-04 16:18","market":"us","language":"en","title":"Tesla shares surged more than 2% to a new high in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1184547180","media":"Tiger Newspress","summary":"Tesla shares surged more than 2% to a new high in premarket trading.","content":"<p>Tesla shares surged more than 2% to a new high in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a05912968b722506b7360bb563f229\" tg-width=\"850\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla shares surged more than 2% to a new high in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla shares surged more than 2% to a new high in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-04 16:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tesla shares surged more than 2% to a new high in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/e3a05912968b722506b7360bb563f229\" tg-width=\"850\" tg-height=\"618\" width=\"100%\" height=\"auto\"></p>\n<p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184547180","content_text":"Tesla shares surged more than 2% to a new high in premarket trading.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":2403,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841172174,"gmtCreate":1635898741641,"gmtModify":1635898741796,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"Tonight is crucial","listText":"Tonight is crucial","text":"Tonight is crucial","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841172174","repostId":"2180736486","repostType":4,"isVote":1,"tweetType":1,"viewCount":1813,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":857046854,"gmtCreate":1635498736986,"gmtModify":1635498984025,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ASML\">$ASML Holding NV(ASML)$</a>Rise rise","listText":"<a href=\"https://laohu8.com/S/ASML\">$ASML Holding NV(ASML)$</a>Rise rise","text":"$ASML Holding NV(ASML)$Rise rise","images":[{"img":"https://static.tigerbbs.com/9ff540605abf19a5c0f68ec5ec6a1970","width":"1080","height":"3362"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/857046854","isVote":1,"tweetType":1,"viewCount":1582,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":165577747,"gmtCreate":1624153861589,"gmtModify":1634010237799,"author":{"id":"3554811401768317","authorId":"3554811401768317","name":"HUAT8","avatar":"https://static.tigerbbs.com/285db011b214150701fb409a7a900a7b","crmLevel":12,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3554811401768317","authorIdStr":"3554811401768317"},"themes":[],"htmlText":"Next week let's see","listText":"Next week let's see","text":"Next week let's see","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/165577747","repostId":"1126454279","repostType":4,"isVote":1,"tweetType":1,"viewCount":1269,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":false}